Olema Pharmaceuticals (OLMA) Shares Outstanding (Weighted Average) (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $102.8 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $102.8 million, up 20.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $102.8 million (up 20.34% YoY), and the FY2025 annual result was $87.0 million, up 48.11% from the prior year.
• Shares Outstanding (Weighted Average) improved to $102.8 million in Q1 2026 per OLMA's latest filing, from $87.0 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $102.8 million in Q1 2026 and troughed at $39.8 million in Q1 2022.
• A 5-year average of $59.1 million and a median of $55.6 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) climbed 1.19% in 2022, then soared 53.72% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $40.0 million in 2022, then gained by 13.13% to $45.2 million in 2023, then grew by 29.83% to $58.7 million in 2024, then surged by 48.11% to $87.0 million in 2025, then rose by 18.15% to $102.8 million in 2026.
• Business Quant data shows OLMA's Shares Outstanding (Weighted Average) at $102.8 million in Q1 2026, $87.0 million in Q4 2025, and $85.7 million in Q3 2025.